Zacks Investment Management Spectrum Pharmaceuticals Inc Transaction History

Zacks Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $17,310 - $62,799	40,256 New	40,256 $17,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $31,004 - $62,008	-44,292 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.63 - $1.59 $27,903 - $70,424	44,292 New	44,292 $57,000
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $107,329 - $202,342	-58,650 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $205,275 - $607,027	58,650 New	58,650 $213,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.